# A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition

> **NCT01557244** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 181 (actual)

## Conditions studied

- Urinary Bladder, Neurogenic

## Interventions

- **DRUG:** Fesoterodine PR 4 mg
- **DRUG:** Fesoterodine PR 8 mg
- **DRUG:** Fesoterodine PR 8 mg
- **DRUG:** Oxybutynin
- **DRUG:** Fesoterodine PR
- **DRUG:** Fesoterodine BIC 2 mg
- **DRUG:** Fesoterodine BIC 4 mg

## Key facts

- **NCT ID:** NCT01557244
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-02
- **Primary completion:** 2019-11-07
- **Final completion:** 2020-02-13
- **Target enrollment:** 181 (ACTUAL)
- **Last updated:** 2021-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01557244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01557244, "A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01557244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*